Access-H20: Sensor-driven smart faucet to enable and empower independent drinking and grooming for individuals impacted by spinal cord injury

项目总结/摘要 I-Corps ™计划的目标是通过以下方式加速生物医学研究向市场的转化： 为SBIR和STTR赠款接受者提供创新和创业领域的培训。根据该方案， NIH将促进Nasoni的发展，重点是教授Nasoni研究人员如何获得更清晰的 了解其发明在市场上的价值，并最终如何从 把研究实验室带入商业世界该计划旨在补充范围内的活动 母公司SBIR第一阶段（R43）赠款，以帮助加速来自NIH的Nasoni的Access H2OTM的商业化 资助技术可行性研究。 通过这个项目，Nasoni的I-Corps ™团队将参加一个企业家沉浸式课程。I-Corps ™ 课程使用假设驱动的客户发现方法，以深入了解与以下方面相关的问题： 技术商业化。作为该计划的一部分，纳索尼的团队成员被要求"走出实验室"， 通过进行多次访谈来收集信息（即，100+）与潜在客户、战略合作伙伴和其他 第三方利益相关者。 在课程期间，Nasoni的I-Corps ™团队将与I-Corps讲师和其他团队分享他们学到的知识，从而获得 对SBIR资助下正在开发的技术的潜在影响的新见解。预计各国 在I-Corps ™计划期间获得的反馈和学习将有助于为Nasoni的第二阶段SBIR项目提供信息， 商业化战略。 .

PROJECT SUMMARY/ABSTRACT The goal of the I-Corps™ Program is to accelerate the translation of biomedical research to the marketplace by providing training to SBIR and STTR grantees in the areas of innovation and entrepreneurship. Under this program, the NIH will foster the development of Nasoni, with a focus on teaching Nasoni researchers how to gain a clearer understanding of the value of its inventions in the marketplace, and ultimately how to advance their technologies from the research lab into the commercial world. This program is designed to complement activities within the scope of the parent SBIR Phase I (R43) grant, to help accelerate the commercialization of Nasoni's Access H2OTM derived from NIH funded technical feasibility studies. Through this program, Nasoni's I-Corps™ team will participate in an entrepreneurial immersion course. The I-Corps™ curriculum uses a hypothesis-driven method of customer discovery to gain insights into the issues associated with technology commercialization. As part of this program, Nasoni's team members are required to get "out of the lab" and gather information by conducting many interviews (i.e., 100+) with potential customers, strategic partners, and other third-party stakeholders. During the course, Nasoni's I-Corps™ team will share what they learn with I-Corps instructors and other teams, gaining new insights into the prospective impact of the technology being developed under the SBIR grant. It is anticipated that the feedback and learning gained during the I-Corps™ program will help inform Nasoni's Phase II SBIR project and commercialization strategies. .